Year archive

X BIOSCIENCE PUBLIC COMPANY LIMITED — 2026 filings

All 100 regulatory filings released by X BIOSCIENCE PUBLIC COMPANY LIMITED (XBIO) in 2026, sourced directly from the official regulator.

100 Filings

2026 Period

2026 filings (100)

Filing	Released	Lang
Notification of the Resolution of the Company's BOD Meeting No. 9/2026 Regarding the Approval of the Disposal of Ordinary Shares in Subsidiary, Bake Cheese Tart (Thailand) Co., Ltd. ("BAKE"), Constitu Capital/Financing Update	2026-07-02	English
Notification of the Resolution of the Company's BOD Meeting No. 9/2026 Regarding the Approval of the Disposal of Ordinary Shares in Subsidiary, Bake Cheese Tart (Thailand) Co., Ltd. ("BAKE"), Constitu M&A Activity	2026-06-26	English
Disclosure of the Invitation Letter to the Extraordinary General Meeting of Shareholders No. 2/2026 on the Company's Website Report Publication Announcement	2026-06-26	English
Clarification of news or information requested by SET Regulatory Filings Q1 2026	2026-06-16	English
Notification the exercise of XBIO-W8 Share Issue/Capital Change	2026-06-15	English
Right Adjustment of XBIO-W6, XBIO-W7, XBIO-W8 (Revised) Capital/Financing Update	2026-06-15	English
Right Adjustment of XBIO-W6, XBIO-W7, XBIO-W8 Share Issue/Capital Change	2026-06-15	English
Report on the results of the Exercise of XBIO-W8 (F53-5) Share Issue/Capital Change	2026-06-08	English
Notification of the BOD Meeting No.8/2026: Resignation & Appointment of Directors, CFO Appointment, Head Office Location, Capital Increase, Issuance of XBIO-W9 to Existing Shareholders, Determination Regulatory Filings	2026-06-08	English
Notification of the BOD Meeting No.8/2026: Resignation & Appointment of Directors, CFO Appointment, Head Office Location, Capital Increase, Issuance of XBIO-W9 to Existing Shareholders, Determination Regulatory Filings	2026-06-05	English
Changed information of CFO Board/Management Information	2026-06-04	English
Appointment of a New Director in Replacement of the Resigned Director (Revised) Regulatory Filings	2026-06-04	English
Notification of the BOD Meeting No.8/2026: Resignation & Appointment of Directors, CFO Appointment, Head Office Location, Capital Increase, Issuance of XBIO-W9 to Existing Shareholders, Determination Regulatory Filings	2026-06-02	English
CC sign lifted on the securities of XBIO Regulatory Filings	2026-06-02	English
Notification of the BOD Meeting No.8/2026 : Resignation & Appointment of Directors, CFO Appointment, Head Office Location, Capital Increase, Issuance of XBIO-W9 to Existing Shareholders, Determination Regulatory Filings	2026-06-02	English
Appointment of a New Director in Replacement of the Resigned Director Board/Management Information	2026-06-02	English
Notification of the BOD Meeting No. 8/2026 re: Resignation and Appointment of Directors, CFO Appointment, Headquarter Location, Capital Increase, Issuance of XBIO-W9 to Existing Shareholders, Determin Regulatory Filings	2026-06-02	English
Report of the Public Presentation Management Reports	2026-06-02	English
Notification convening date of the Public Presentation Report Publication Announcement	2026-05-26	English
CC sign posted on XBIO's securities Regulatory Filings	2026-05-26	English
Notification of the registration of the decrease of the Company's registered capital and the increase of the Company's registered capital to the Department of Business Development, Ministry of Commerc Share Issue/Capital Change	2026-05-21	English
Financial Performance Quarter 1 (F45) (Reviewed) Report Publication Announcement	2026-05-18	English
Notification the exercise of XBIO-W8 Share Issue/Capital Change	2026-05-18	English
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026 Interim / Quarterly Report Q1 2026	2026-05-18	English
Financial Statement Quarter 1/2026 (Reviewed) Regulatory Filings	2026-05-18	English
Publication of the Minutes of the 2026 Annual General Meeting of Shareholders on the Company's Website Report Publication Announcement	2026-05-14	English
Submission of the report on the result of the tender offer for X BIOSCIENCE PUBLIC COMPANY LIMITED (Form 256-2) (Revised) M&A Activity	2026-05-11	English
Opinion of the Company on the Tender Offer (Form 250-2) of X Bioscience Public Company Limited (Revised) Regulatory Filings	2026-05-07	English
Report on the results of the Exercise of XBIO-W8 (F53-5) (Revised) Share Issue/Capital Change	2026-05-07	English
Resignation from the position of Chief Operating Officer (COO) - Food Division of the Company Board/Management Information	2026-05-05	English
Report on the results of the Exercise of XBIO-W8 (F53-5) Share Issue/Capital Change	2026-05-05	English
Notification of the Resolutions of the 2026 Annual General Meeting of Shareholders Declaration of Voting Results & Voting Rights Announcements	2026-04-30	English
Clarification of news or information requested by SET (Revised) Regulatory Filings	2026-04-30	English
Submission of the Report on Preliminary Result of the Tender Offer for X Bioscience Public Company Limited (Form 247-6-Khor) (Revised) M&A Activity	2026-04-29	English
Appointment of CFO (Acting) Board/Management Information	2026-04-27	English
Clarification of news or information requested by SET Regulatory Filings	2026-04-20	English
The acquisition of a new indirect subsidiary Regulatory Filings	2026-04-20	English
Opinion of the Company on the Tender Offer (Form 250-2) of X Bioscience Public Company Limited Regulatory Filings	2026-04-17	English
Resignation of CFO Board/Management Information	2026-04-17	English
Disclosure of the Invitation Letter to the Annual General Meeting of Shareholders 2026 on the Company's Website Report Publication Announcement	2026-04-16	English
Notification the exercise of XBIO-W8 Share Issue/Capital Change	2026-04-16	English
New shares of XBIO to be traded on April 16, 2026 Share Issue/Capital Change	2026-04-10	English
Report on the results of the Exercise of XBIO-W8 (F53-5) Share Issue/Capital Change	2026-04-02	English
Notification of the Receipt of a Tender Offer (Form 247-4) of X Bioscience Public Company Limited (Revised) M&A Activity	2026-03-23	English
Notification of Board Meeting No. 4/2026 Resolutions: Approval of 2025 Financial Statements, No Dividend, Directors' Election and Remuneration, Auditor Appointment, Capital Reduction and Increase, Sha Regulatory Filings	2026-03-19	English
Notification of Board Meeting No. 4/2026 Resolutions: Approval of 2025 Financial Statements, No Dividend, Directors' Election and Remuneration, Auditor Appointment, Capital Reduction and Increase, Sha Regulatory Filings	2026-03-18	English
Information Memorandum on the Description, Condition and Major Characteristics of Warrants to purchase newly issued ordinary shares of X Bioscience Public Company Limited No. 8 (XBIO-W8) (Revised) Regulatory Filings	2026-03-18	English
SET adds new listed securities : XBIO-W8 to be traded on March 19, 2026 Share Issue/Capital Change	2026-03-18	English
SET temporarily posted P sign on XBIO due to Auto Pause. Regulatory Filings	2026-03-17	English
New shares of XBIO to be traded on March 18, 2026 Share Issue/Capital Change	2026-03-17	English
Notification the exercise of XBIO-W8 Share Issue/Capital Change	2026-03-16	English
SET temporarily posted P sign on XBIO due to Auto Pause. Regulatory Filings	2026-03-16	English
SET temporarily posted P sign on XBIO due to Auto Pause. Regulatory Filings	2026-03-13	English
Declaration of Intention to Acquire Securities for Business Takeover (Form 247-3) (Revised) M&A Activity	2026-03-13	English
New shares of XBIO to be traded on March 16, 2026 Share Issue/Capital Change	2026-03-13	English
Declaration of Intention to Acquire Securities for Business Takeover (Form 247-3) (Revised) M&A Activity	2026-03-12	English
Declaration of Intention to Acquire Securities for Business Takeover (Form 247-3) M&A Activity	2026-03-12	English
Declaration of Intention to Acquire Securities for Business Takeover (Form 247-3) M&A Activity	2026-03-12	English
Report on the results of sale of common shares offered to all common shares' shareholders (F53-5) Share Issue/Capital Change	2026-03-12	English
Report of the Public Presentation Management Reports	2026-03-12	English
Report on the results of the Exercise of XBIO-W8 (F53-5) (Revised) Share Issue/Capital Change	2026-03-11	English
Report on the results of the Exercise of XBIO-W8 (F53-5) (Revised) Share Issue/Capital Change	2026-03-09	English
Report on the results of the Exercise of XBIO-W8 (F53-5) Share Issue/Capital Change	2026-03-06	English
Clarification of Information Regarding the Shares Reserved for the Exercise of Warrants XBIO-W8 Capital/Financing Update	2026-03-06	English
Notification convening date of the Public Presentation Report Publication Announcement	2026-03-05	English
Notification of the BOD Meeting No. 3/2026 re: Share Acquisition in Chokdee Dimsum Corporation Co., Ltd. (Asset Acquisition), Appointment of Director & Change in Directors' Signing Authority, Appoint Regulatory Filings	2026-02-26	English
Financial Statement Yearly 2025 (Audited) Revized Regulatory Filings	2026-02-25	English
Financial Statement Yearly 2025 (Audited) Revized Regulatory Filings	2026-02-25	English
Financial Performance Yearly (F45) (Audited) Report Publication Announcement	2026-02-25	English
Notification of the BOD Meeting No. 3/2026 re: Share Acquisition in Chokdee Dimsum Corporation Co., Ltd. (Asset Acquisition), Appointment of Director & Change in Authorized Directors' Signing Authorit M&A Activity	2026-02-24	English
Management Discussion and Analysis Yearly Ending 31 Dec 2025 Management Reports	2026-02-24	English
Financial Performance Yearly (F45) (Reviewed) Report Publication Announcement	2026-02-24	English
Financial Statement Yearly 2025 (Reviewed) Regulatory Filings	2026-02-24	English
Publication of Additional Channel for Submission of Subscription Information for Newly Issued Ordinary Shares of X Bioscience Public Company Limited Regulatory Filings	2026-02-23	English
Notification of the registration of the decrease of the Company's registered capital and the increase of the Company's registered capital to the Department of Business Development, Ministry of Commerc Share Issue/Capital Change	2026-02-17	English
Publication of the Minutes of the Extraordinary General Meeting of Shareholders No.1/2026 on the Company's Website Report Publication Announcement	2026-02-16	English
Publication of the Notification of the Right to Subscribe for the Newly Issued Ordinary Shares of X Bioscience Public Company Limited on the Company's Website Report Publication Announcement	2026-02-16	English
Notification the exercise of XBIO-W8 Share Issue/Capital Change	2026-02-13	English
Information Memorandum on the Description, Condition and Major Characteristics of Warrants to purchase newly issued ordinary shares of X Bioscience Public Company Limited No. 8 (XBIO-W8) Capital/Financing Update	2026-02-13	English
Notification of the Resolutions of the Company's Board of Directors Meeting No. 2/2026 Regarding the Appointment of a New Director in Replacement of the Resigned Director and the Amendment of Authoriz Board/Management Information	2026-02-11	English
Report on Repayment of Loan to Peer For You Public Company Limited Capital/Financing Update	2026-02-05	English
Notification of the Resolutions of the Extraordinary General Meeting of Shareholders No. 1/2026 Declaration of Voting Results & Voting Rights Announcements	2026-02-04	English
Clarification on the Report of Acquisition or Disposal of Securities of the Company (Form 246-2) dated 29 January 2026 (Revised) Regulatory Filings	2026-02-02	English
Report on the use of proceeds from Capital Increase Regulatory Filings	2026-01-30	English
Clarification on the Report of Acquisition or Disposal of Securities of the Company (Form 246-2) dated 29 January 2026 Major Shareholding Notification	2026-01-30	English
Clarification of news or information requested by SET (Revised) Regulatory Filings	2026-01-30	English
Notification of the Resolutions of the Company's BOD Meeting No. 1/2026 Regarding the Resignation of the Independent Director and Chairman of the Board, and the Appointment of the Chairman and Vice Ch Board/Management Information	2026-01-29	English
Report on the results of the sale of warrants offered to shareholders who subscribe for additional shares (F53-5) (Revised) Share Issue/Capital Change	2026-01-26	English
Report on the results of the sale of warrants offered to shareholders who subscribe for additional shares (F53-5) (Revised) Regulatory Filings	2026-01-26	English
Report on the results of the sale of warrants offered to All common shares' shareholders (F53-5) Share Issue/Capital Change	2026-01-26	English
Report on the results of the sale of warrants offered to All common shares' shareholders (F53-5) Share Issue/Capital Change	2026-01-26	English
Clarification of news or information requested by SET Regulatory Filings	2026-01-23	English
Disclosure of the Invitation Letter to the Extraordinary General Meeting of Shareholders No. 1/2026 on the Company's Website Report Publication Announcement	2026-01-23	English
SET temporarily posted P sign on XBIO due to Auto Pause. Regulatory Filings	2026-01-21	English
SET temporarily posted P sign on XBIO due to Auto Pause. Regulatory Filings	2026-01-20	English
SET temporarily posted P sign on XBIO due to Auto Pause. Regulatory Filings	2026-01-12	English
The Resignation of a Director Board/Management Information	2026-01-09	English
SET temporarily posted P sign on XBIO due to Auto Pause. Regulatory Filings	2026-01-09	English
Right Adjustment of XBIO-W6, XBIO-W7 Capital/Financing Update	2026-01-08	English
Notification of BOD Resolutions Meeting No. 17/2025 regarding director appointments, amendment of signing authority, CFO appointment, executive restructuring, capital reduction and increase, Rights Of Capital/Financing Update	2026-01-08	English